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IMPACT OF BODY MASS INDEX ON MORTALITY IN THE VETERANS 
ADMINISTRATION NORMATIVE AGING STUDY 
ANNA L. TYZIK 
ABSTRACT 
 High body mass index (BMI) has been found to be associated with a multitude of 
health issues and its longitudinal effect on mortality needs to be further understood due to 
increasing rates of obesity. The relationship between BMI and mortality is a key public 
health concern due to the rise in obesity prevalence and advancing knowledge of the 
impact of BMI on all aspects of health. 
In order to expand and further contribute to the understanding of the long-term 
impact of BMI on mortality, we utilized prospective, longitudinal data from the Veterans 
Affairs (VA) Normative Aging Study (NAS) to assess the relationship between BMI and 
40-year all-cause and cause-specific mortality in men. Cox regression was used to 
evaluate the relationship between BMI and all-cause and cause-specific (cancer, 
congenital heart disease (CHD), stroke) mortality. 
Of the 1,680 men included in this study, the majority were White (96.7%), born 
between 1920–1929, were between ages 50–59 years, married, completed some college, 
identified as an occasional drinker and a current smoker, and worked in a “white-collar” 
job. This study did not identify any men who had an underweight BMI. 594 men had 
normal BMI, 910 men were overweight, and 176 men were obese. 
After adjusting for confounders, compared to men with normal BMI, overweight 
men had higher risk for CHD mortality (HR=1.33, 95% CI, 0.95–1.86), lower risk for all-
	
	 v 
cause and stroke mortality (HR=0.98, 95% CI, 0.87–1.11, HR=0.88, 95% CI, 0.53–1.45, 
respectively), and no difference in risk for cancer mortality (HR=1.00, 95% CI, 0.82–
1.23). Obese men had higher risk for all-cause and stroke mortality (HR=1.19, 95% CI, 
0.98–1.45, HR=1.26, 95% CI, 0.57–2.79, respectively) and lower risk for CHD and 
cancer mortality (HR=0.87, 95% CI, 0.48–1.58, HR=0.95, 95% CI, 0.68–1.33, 
respectively).  
In conclusion, this study found that men categorized as obese had an increased 
risk of all-cause and stroke mortality, and men categorized as overweight had an 
increased risk of CHD mortality, compared to those with normal BMI. However, due to 
all confidence intervals crossing 1.00, there is a suggestion that BMI had an effect on 
mortality in this sample. These results are limited by selection bias during the NAS 
screening process which selected for healthy men. This may have skewed our results 
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Background and Significance 
Overweight and obesity can lead to a multitude of health conditions, contribute 
significantly to health care costs, and pose a serious public health concern. In particular, 
obesity increases risk for a number of diseases, including diabetes, cardiovascular 
disease, and cancer(1), and contributes to increases in blood pressure and cholesterol 
levels. While there are several ways to calculate obesity, it is often measured using body 
mass index or BMI (kg/m2), which is calculated by dividing weight (in kilograms) by 
height2 (in meters). According to the Centers for Disease Control and Prevention, 
standard BMI categories are defined as normal (18.5–24.9), underweight (below 18.5), 
overweight (25–29.9), and obese (30 and above). (2) They further divide obesity into class 
I (BMI of 30 to <35), class II (BMI of 35 to <40), and class III (BMI of 40 or higher).(2) 
 
BMI and Mortality Risk 
Trend data indicate that the prevalence of obesity in the U.S. has been steadily increasing 
over the past several decades (3–6). Individuals with a BMI above or below normal have a 
greater risk of mortality, and that risk increases in those who are obese(7–12). A meta-
analysis conducted by Aune et. al. found that among healthy never smokers, there was a 
21% (HR=1.21, 95% CI, 1.18–1.25) increased risk for each 5 unit increase in BMI above 
23 kg/m2, and that risk increased when assessing studies with a follow-up period more 
than 6 years (HR=1.27, 95% CI 1.21–1.33). The Prospective Studies Collaboration found 
a 29% (HR=1.29, 95% CI, 1.27–1.39) increased risk of mortality per 5 kg/m2 higher BMI 




mortality per 5kg/m2 lower BMI for BMI range 15–25 kg/m2.(5) Orpana and colleagues 
noted a 36% (HR=1.36, 95% CI, 1.00–1.85) increased risk of death for class II obesity, 
while overweight had a protective effect on mortality (HR=0.83, 95% CI, 0.72–0.96).(7) 
Additional studies have shown a V- or U-shape, where risk of death is higher for those 
above or below the normal BMI range and the lowest risk lies with those who are 
categorized as having a normal BMI.(4,8,13–14) However, other studies have found that 
individuals who are categorized as overweight have a greater risk of mortality than those 
who are underweight or obese.(4,7,8,12,15) These discrepancies may be explained by 
differing study design methodologies. 
 
Risk Factors 
To enhance our understanding of this complex relationship, it is important to identify risk 
factors and vulnerabilities that lead to high BMI. In conjunction, determining the various 
trajectories of BMI allows for the discovery and development of more targeted 
prevention measures. The majority of current literature has identified differences in the 
impact of BMI on mortality in the context of gender, demographic (race, education, 
occupation), and lifestyle (marital status, smoking, and alcohol use) variables. 
Utilizing rural and urban data from 12 southeastern U.S. states, Cohen et. al. noted that 
among Whites, the lowest mortality risk occurred among those with BMIs between 25 
and 29 kg/m2, and hazard ratios rose thereafter, reaching a 40%–50% excess among those 
in obesity class III (BMI ≥40 kg/m2); however, among Blacks, obesity (BMI 30.0–34.9 




conducted with a large prospective cohort of White and Black U.S. adults noted that 
underweight (BMI 15.0–18.4 kg/m2) was associated with a higher risk of mortality 
compared to normal BMI (18.5–19.9 kg/m2) in both Black and White men. Underweight 
Black men had a higher risk of mortality only if they had prevalent disease, defined as a 
history of cancer (except non-melanoma skin cancer), heart disease, stroke, respiratory 
diseases (chronic bronchitis, emphysema, or asthma), current illness of any kind, or 
weight loss of 10 or more lbs (4.5 kg) in the previous year.(17) In a study assessing gender 
differences, being underweight was associated with a significantly increased risk of 
mortality for both men and women; being in obesity class II+ (>35 kg/m2) was associated 
with a significantly increased risk of mortality for men, but not for women; and being 
overweight (25–<30 kg/m2) was associated with a significantly decreased risk for 
women, but was associated with a significantly increased risk for men.(7) Mehta and 
Chang found that for men and women, being overweight (25.0–29.9 kg/m2) or class I 
obese (30.0–34.9 kg/m2) was not associated with higher risk of mortality, but being class 
II/III obese (≥35.0 kg/m2) did show significantly higher risk, and was higher in males 
than females.(13) In an assessment of adult body mass trajectories and risk factors for 
belonging to a specific body mass trajectory groups (‘normal weight’, ‘overweight’, ‘late 
adulthood obesity’, and ‘early adulthood obesity’), authors found that males, Blacks, and 
those born in a later cohort (aged 18–20 years in 1981) had higher odds of becoming 
‘overweight’ (average trajectory starting in normal BMI range and terminating in 
overweight range at age 49), developing ‘late adulthood obesity’ (average trajectory 




range until age 49 years), and developing ‘early adulthood obesity’ (average trajectory 
starting in obese BMI range and remaining there until age 49 years) groups.(16) Authors 
also noted that more education and years married lowered the trajectory of weight gain 
rates within each group. 
Risk of death has also been shown to vary across/among age groups. Cohen et. al. noted 
that among whites, the hazard ratios for mortality associated with extreme obesity (>40 
kg/m2) were somewhat higher in men (HR=1.77, 95% CI, 1.13–2.75) and women (HR= 
1.69, 95% CI, 1.19–2.39) age 55 and older, compared to men (HR=0.98, 95% CI, 0.65–
1.48) and women (HR=1.35, 95% CI, 0.94–1.94) younger than age 55, and compared to 
men and women with normal BMI.(9) Orpana et. al. noted increased risk of death for 
those ages 60 and older who were underweight (<18.5 kg/m2) (RR=1.88, 95% CI, 1.32–
2.68) and those who were obese (BMI ≥35) (RR=1.25, 95% CI, 0.83–1.90). For those 
ages 25–59, increased risk was only noted for those who were obese (RR=1.53, 95% CI, 
0.91–2.58) (7) Further study of the patterns of BMI and mortality, with a focus on 
demographic differences, is necessary in order to gain a better understanding of the 
association and provide more individualized interventions. 
Assessing cause-specific mortality is an important addition to studies of BMI and 
mortality, due to BMI being associated with various diseases. The two most studied 
causes of mortality associated with BMI are cardiovascular disease and cancer. Pooled 
results from a study assessing all-cause, cancer, and cardiovascular mortality, utilizing 
data from the Nurses’ Health Study (NHS, 1980–2012) and the Health Professionals 




compared to those with BMI of 22.5–24.9 is increased in those with a BMI of <18.5 
(HR=1.85, 95% CI, 1.70–2.01), 18.5–22.4 (HR=1.12, 95% CI, 1.08–1.16), 27.5–29.9 
(HR=1.06, 95% CI, 1.02–1.11), 30.0–34.9 (HR=1.17, 95% CI, 1.12–1.22), 35.0–39.9 
(HR=1.55, 95% CI, 1.45–1.66) and ≥40 (HR=1.92, 95% CI, 1.74–2.11). Those with a 
BMI 25–27.4 had minimally decreased risk of all-cause mortality (HR=0.99, 95% CI, 
0.96–1.03). Similar increased risk was also seen for cause-specific mortality.(18) 
 
Study Design 
Longitudinal studies are crucial to understanding the long-term impact of BMI on 
mortality, and some suggest that study design, such as length of follow-up, the number of 
BMI categories, and types of confounders being assessed, are important in clarifying the 
effect of BMI on risk of death.(8,15,18–21) Two meta-analyses noted that among studies 
assessing mortality with a short follow-up period, low BMI was associated with a higher 
risk of dying than high BMI, however, this association reversed among studies assessing 
mortality with a longer follow-up, where those who reported high BMI at time of 
interview had higher mortality risk than those with low BMI.(8,22) A study utilizing data 
from the first cohort of the Framingham Heart Study first assessed the impact of differing 
study designs on results when assessing BMI and mortality, then assessed the time-
varying relationship between BMI and mortality. They found for men, using BMI closer 
to baseline and increasing the length of follow-up impacts study results. They also note 
that for men, mortality hazard ratios increase as BMI increases and they had lower risk of 





Though there are many studies assessing the relationship between BMI and mortality, 
seeing variability in this relationship over time indicates that there is greater need for 
longitudinal studies to analyze this association in more detail. 
 
Thesis Study 
The relationship between BMI and mortality is a key public health concern due to the rise 
in obesity prevalence and advancing knowledge of the impact of BMI on all aspects of 
health. In order to expand and further contribute to the understanding of the long-term 
impact of BMI on mortality among midlife and older adults, this thesis sought to examine 
the impact of BMI on 40-year all-cause and cause-specific mortality in a prospective 
cohort of Veterans from the Veterans Affairs (VA) Normative Aging Study (NAS). Few 
studies assess the relationship between BMI and all-cause and cause-specific mortality in 
a geographically and socially stable, healthy sample of men over a 40-year period. We 
hypothesize that mortality risk will be highest in men who are obese compared to men 
with normal BMI and men who have a BMI ≥25 kg/m2 will have a greater risk of all-







The NAS cohort consists of over 6,000 men who were screened between 1961 and 1970 
for good health, geographic stability and social ties in Boston, with 2,280 subsequently 
enrolled into the study. Participants were aged 21–81 years (Mean=42, SD=9) at 
enrollment and represented the socioeconomic characteristics of Boston in 1970 in terms 
of race and occupation. Since enrollment, men have reported regularly (every 3 years 
since 1986) for medical examinations and have periodically completed mail surveys. The 
exclusion criteria for enrollment in the NAS cohort were as follows: (1) men who were in 
poor health (e.g., history or presence of heart disease, cancer, peptic ulcer, gout, recurrent 
asthma, bronchitis, and sinusitis, and clinical evidence of hypertension and glucose 
intolerance, (2) men not planning to remain in the Boston area, and (3) men who had 
minimal social ties in the Boston area. 
 
Thesis Cohort 
The current study is based on a secondary analysis of data collected from a subset of the 
cohort initially enrolled in the NAS. It consists of 1,680 men who had continued 
participation in the NAS and had initial anthropometric exam between 1975 to 1981 and 
excludes men if they died or were lost to follow-up within the first 5 years of their initial 
anthropometric exam. Follow-up for this study began on January 1, 1974 and continued 





Definition of Variables 
The exposure variable for this study is BMI. Height and weight were measured by trained 
study personnel at baseline and converted to BMI (kg/m2).  The outcome variables were 
all-cause and cause-specific (cancer, CHD, stroke) mortality. We chose cancer, CHD, and 
stroke mortalities because they are the most common cause of death among older people, 
and for which we had enough cases in the thesis cohort. There was low prevalence of 
stroke in the NAS, however, it is a leading cause of death among the elderly, so we chose 
to include it in our analyses. Mortality was tracked through periodic mailings to 
participants and notification from next-of-kin or postal authorities. Records of the 
Department of Veterans Affairs and the Social Security Administration (Death Master 
File) were regularly monitored for any unreported deaths. When deaths were reported, a 
death certificate was obtained and coded for cause of death, which was classified as 
ischemic cardiovascular disease (ICD-9 codes 410-414), cancer (ICD-9 codes 140-
208.9), and stroke (ICD-9 codes 430-438). 
 
Confounders: Demographic and Lifestyle Measures 
Demographic characteristics and lifestyle factors were considered potential confounders 
in this analysis and obtained from self-reported data at baseline. Potential confounders 
were identified based on evidence from previous studies that suggested an effect of that 
variable on either BMI or mortality. These included birth cohort (1896–1909, 1910–1919, 
1920–1929, 1930–1949), marital status (married, not married), education (grade school or 




graduate), employment type (dark blue-collar, light blue-collar), and smoking status 






Descriptive variables were stratified by BMI category and compared using Chi Square 
tests. Cox regression was used to determine the unadjusted and adjusted hazard ratios for 
the association between BMI and each descriptive variable with each mortality outcome. 
Potential confounding variables were added to the unadjusted model for each mortality 
outcome one at a time. The hazard ratio for each variable was assessed for a 10%change 
in the crude estimate in any of the BMI categories. If the change in estimate met or 
exceeded 10% for any of the BMI categories, the variable was retained in the final 
adjusted model as a confounder. A change in estimate of less than 10% suggested that the 
variable was not a confounder and it was excluded from the adjusted model.. We used a 
higher change in estimate cutoff for CHD and stroke mortality due to small sample size 
for those outcomes and the high number of categories for each variable. The change in 
estimate for CHD mortality was 20% and 15% for stroke mortality. All analyses were 






Characterization of Study Population 
A sample of 1,680 men was identified for descriptive analysis. 183 men were excluded 
from the final analytic dataset for CHD mortality due to missing occupation data. Thus, 
the final dataset used for CHD mortality included 1,591 men. The final dataset for all-
cause, cancer, and stroke mortality analyses included 1,680 men. Table 1 shows 
descriptive characteristics stratified by BMI category. This study did not identify any 
men who had an underweight BMI. 594 men had normal BMI, 910 men were 
overweight, and 176 men were obese. Majority of the men were White (96.7%), born 
between 1920–1929, were between ages 50–59 years, married, completed some college, 
identified as an occasional drinker and a current smoker, and worked in a “white-collar” 
job. 22% of men with normal BMI and 19% of overweight men had their first exam in 
1975 and 18% of obese men had their first exam in 1979. 
 
Crude Results, Identification of Confounders and Multivariate Results 
Tables 2–5 show the univariate analysis for the unadjusted association between BMI 
category and each mortality outcome. Overweight men had higher risk of all-cause and 
CHD mortality (HR=1.05, 95% CI, 0.98–1.12, HR=1.73, 95% CI, 1.23–2.42, 
respectively), had lower risk of stroke mortality (HR=0.95, 95% CI, 0.59–1.55), and had 
no difference in risk of cancer mortality (HR=1.00, 95% CI, 0.82–1.23) compared to men 
with normal BMI. Obese men had higher risk of all-cause and CHD mortality (HR=1.04, 




cancer and stroke mortality (HR=0.95, 95% CI, 0.68–1.33, HR=0.91, 95% CI, 0.40–2.06, 
respectively) compared to men with normal BMI.  
Tables 6–9 show the univariate analysis for risk factors and their unadjusted association 
with each mortality outcome. For all-cause mortality, marital status, smoking status, 
occupation, and age group were associated with higher risk, while birth cohort, education, 
drinking status, and the year of the first anthropometric exam were associated with lower 
risk. For cancer mortality, birth cohort, marital status, drinking status, smoking status, 
occupation, and age group were associated with higher risk, while education was 
associated with lower risk. For CHD mortality, marital status, smoking status, 
occupation, and age group were associated with higher risk, while birth cohort, education, 
drinking status, and year of first anthropometric exam were associated with a lower risk. 
For stroke mortality, education, drinking status, and age group were associated with 
higher risk, while marital status, smoking status, and year of first anthropometric exam 
were associated with a lower risk. Birth cohort categories 1920–1929 and 1930–1949 
were associated with lower risk, while the category 1910–1919 had an increased risk of 
stroke mortality, compared to the referent category (1896–1909). Additionally, for stroke 
mortality, occupation status ‘dark-blue collar’ had an increased risk, while ‘light-blue 
risk’ had a decreased risk, compared to the referent category (‘white collar’). 
Tables 10–13 show the identification of potential confounders for each mortality 
outcome. Using a 10% change in estimate, birth cohort was identified as a potential 
confounder for all-cause mortality. Using a 10% change in estimate, no confounders were 




education level, smoking status, and employment type were identified as potential 
confounders for CHD mortality. Using a 15% change in estimate, birth cohort was 
identified as a potential confounder for stroke mortality.  
Tables 14–17 show the comparison of unadjusted to adjusted hazard ratios for each 
mortality outcome. Adjusted models show overweight men had higher risk of CHD 
(HR=1.33, 95% CI, 0.95–1.86), lower risk of all-cause and stroke mortality (HR=0.98, 
95% CI, 0.87–1.11, HR=0.88, 95% CI, 0.53–1.45, respectively), and no difference in risk 
of cancer mortality (HR=1.00, 95% CI, 0.82–1.23) compared to men with normal BMI. 
Obese men had higher risk of all-cause and stroke mortality (HR=1.19, 95% CI, 0.98–
1.45, HR=1.26, 95% CI, 0.57–2.79, respectively), and lower risk in CHD and cancer 
mortality (HR=0.87, 95% CI, 0.48–1.58, HR=0.95, 95% CI, 0.68–1.33, respectively) 






The purpose of this analysis was to assess the impact of BMI on 40-year all-cause and 
cause-specific (cancer, CHD, stroke) mortality in men. We first hypothesized that 
mortality risk would be highest in men who are obese compared to men with normal 
BMI. Our analyses found that among this cohort of men, after adjusting for confounders, 
obese men had higher mortality risk of all-cause and stroke mortality compared to men 
with normal BMI. Our second hypothesis, men with a BMI ≥ 25 kg/m2 would have 
increased risk of any cause mortality, was found for overweight men who had a higher 
risk of CHD mortality and obese men who had a higher risk of all-cause and stroke 
mortality compared to men with normal BMI. Obese men had the highest risk of stroke 
mortality and overweight men had the highest risk of CHD mortality compared to men 
with normal BMI. Analyses also indicated that obese men had the lowest risk and 
overweight men had no difference in risk of cancer mortality compared to men with 
normal BMI. Though we did not confirm our hypotheses, all confidence intervals crossed 
1.00, suggesting that BMI has some effect on all-cause and cause-specific mortality in 
this sample. 
It has been well-noted that individuals with a BMI above what is categorized as normal 
have an increased risk of mortality(3–9), however, the mixed results of the present study 
may be the result of several factors. While study design and analytical decisions 
contributed to our findings, men in the NAS cohort were selected on the basis of their 
good health, specifically in relation to heart disease, leading to above-average health, 




by this type of selection bias, skewing our data toward the null. 
Unlike other studies evaluating the longitudinal relationship between BMI and mortality, 
this analysis assessed the 40-year impact of BMI on mortality among men enrolled in 
midlife and older ages, which affords this study a decided advantage. Additionally, 
trained study staff measured height and weight allowing for less misclassification of 
BMI, compared to studies using self-reported height and weight, which can lead to 
increased misclassification bias. Although this study has some advantages over 
comparative studies, we identified multiple limitations to our study relating to confounder 
data and study design. 
Gender differences were unable to be assessed, as women were not included in the NAS 
and while the study cohort was representative of the racial makeup of Boston, MA in the 
1970’s, the majority White sample did not allow for racial differences to be assessed. Due 
to the homogenous study sample, results do not allow for generalizability to the broader 
population; however, it allows for a more detailed insight into this specific population by 
reducing sources of variability, such as measurement and systematic errors and 
misclassification bias. As previously noted, this study did not assess all identified 
confounders associated with BMI and mortality, such as medication use and physical 
activity, among others. The dynamics of health behavior may differ in later life and not 
assessing or controlling for such change will have implications on study results. 
There were several analytical limitations to this study. There were no underweight men 




which prior studies show is a contributing factor to understanding this relationship. We 
chose to exclude men who died or were lost to follow-up within 5 years of their initial 
anthropometric exam, which further selected men with above-average health. Prior 
studies note mixed outcomes when deaths occurring during the first few years of follow-
up are excluded.(19–20,26) Confounder variables had multiple categories and when 
combined with small sample sizes for some mortality outcomes, this could lead to 
decreased power, further skewing our results toward the null. Additionally, while there is 
a long follow-up for this study, we did not assess BMI as a time-varying covariate. 
Weight, and subsequently BMI, has the potential to fluctuate over a lifetime due to 
myriad intentional and unintentional causes, leading to increased risk for mortality.(24) 
Without assessing this fluctuation and adjusting for it’s potential to influence mortality 
risk, our estimates may skew away from the null. 
Next steps for this study will be to assess changes in BMI over time to have a more 
complete understanding of the longitudinal impact of BMI on mortality risk in this 
cohort. Re-assessing confounders used and how they are structured will be important to 
increase power in the study and add more clarity to these associations. Additionally, we 
will assess BMI as a time-varying covariate to account for lifetime fluctuations in weight 
and assess whether follow-up time influences this relationship. Future studies could focus 
on the inclusion of women and minorities, as well as using other measures of obesity, 
such as waist circumference. Utilizing several methods to determine obesity would 
contribute to a clearer indication of the relationship between weight/BMI and mortality, 




widely known that gender and race are associated with developing various health 
conditions/causes of death, such as Black women being at higher risk of dying from 
breast cancer and heart disease, compared to non-Hispanic white women.(25) Since 
several studies have found differences in the association between BMI and mortality for 
both gender and race, including a more diverse sample with regard to race and gender 
would help clarify this relationship. 
Overall, we did not confirm our hypotheses that men who have a higher body mass index 
(BMI ≥25 kg/m2) will have a greater risk of all-cause, CHD, cancer, and stroke mortality 
compared to men who do not have a normal BMI. Our hypothesis that mortality risk is 
highest in men who are obese compared to men who are of normal BMI range was 
confirmed for all-cause and stroke mortality, but not for cancer or CHD mortality. A 
likely reason for this is the above-average health of the sample at baseline, specifically as 
it related to heart disease, causing selection bias and skewing results toward the null. 
However, this cohort provides a unique opportunity to look at the impact of BMI on 
mortality in an initially healthy sample of White men, over a long period of time. If future 
analyses show a greater risk of 40-year all-cause and cause-specific mortality among 
those with a higher BMI, long-term, targeted efforts with the aim of maintaining a 
healthy weight over time. Specifically, identification of high impact, low cost 
interventions, such as nutrition and exercise programs could lead to improved health and 





Table 1. Descriptive Characteristics 
 
Characteristic BMI Category 































































































































Dark blue collar 


















































































Normal 417 594 70.20 Ref (-) 
Overweight 670 910 73.63 1.05 (0.98–1.12) 
Obese 129 176 73.30 1.04 (0.94–1.16) 
 
 














Normal 124 594 20.88 Ref (-) 
Overweight 191 910 20.99 1.00 (0.82–1.23) 
Obese 35 176 19.89 0.95 (0.68–1.33) 
 
 














Normal 42 594 7.07 Ref (-) 
Overweight 111 910 12.20 1.73 (1.23–2.42) 
Obese 22 176 12.50 1.77 (1.09–2.88) 
 
 














Normal 26 594 4.38 Ref (-) 
Overweight 38 910 4.18 0.95 (0.59–1.55) 














































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 10. Identification of Confounders for All-Cause Mortality 
 
All-Cause MortalityA 
  Adjusted for: 




























Normal Ref Ref Ref Ref Ref Ref Ref Ref 






























AAssessed for a >10% change in estimate; *Variable retained in the final model 
 
 
Table 11. Identification of Confounders for Cancer Mortality 
 
Cancer MortalityA 
 Adjusted for: 


























Normal Ref Ref Ref Ref Ref Ref Ref Ref 



































Table 12. Identification of Confounders for CHD Mortality 
 
CHD MortalityB 
 Adjusted for: 


























Normal Ref Ref Ref Ref Ref Ref Ref Ref 






























BAssessed for a 20% change in estimate; *Variable retained in the final model 
 
Table 13. Identification of Confounders for Stroke Mortality 
 
Stroke MortalityC 
 Adjusted for: 


























Normal Ref Ref Ref Ref Ref Ref Ref Ref 


































Table 14. Comparison of Unadjusted and Adjusted Hazard Ratios for All-Cause 
Mortality by BMI Category 
 
All-Cause Mortality 
BMI Category Crude HR (95% CI) Adjusted HR* (95% CI) 
Normal Ref (-) Ref (-) 
Overweight 1.05 (0.98–1.12) 0.98 (0.87–1.11) 
Obese 1.04 (0.94–1.16) 1.19 (0.98–1.45) 
*Adjusted for Birth Cohort 
 
Table 15. Comparison of Unadjusted and Adjusted Hazard Ratios for Cancer Mortality 
by BMI Category 
 
Cancer Mortality 
BMI Category Crude HR (95% CI) Adjusted HR (95% CI)# 
Normal Ref (-) ----- 
Overweight 1.00 (0.82–1.23) ----- 
Obese 0.95 (0.68–1.33) ----- 
#Only unadjusted results are presented since no confounders were identified 
 




BMI Category Crude HR (95% CI) Adjusted HR+ (95% CI) 
Normal Ref (-) Ref (-) 
Overweight 1.73 (1.23–2.42) 1.33 (0.95–1.86) 
Obese 1.77 (1.09–2.88) 0.87 (0.48–1.58) 
+ Adjusted for Marital Status, Education Level, Smoking Status, and Occupation SES 
 




BMI Category Crude HR (95% CI) Adjusted HR* (95% CI) 
Normal Ref (-) Ref (-) 
Overweight 0.95 (0.59–1.55) 0.88 (0.53–1.45) 
Obese 0.91 (0.40–2.06) 1.26 (0.57–2.79) 
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